We are live on ! Find out more
EHWM

Eads & Heald Wealth Management Portfolio holdings

AUM $204M
1-Year Est. Return 28.27%
This Fund
S&P 500
This Quarter Est. Return
+10.53%
1 Year Est. Return
+28.27%
3 Year Est. Return
+84.36%
5 Year Est. Return
+119.71%
10 Year Est. Return
+418.36%
AUM
$186M
AUM Growth
+$18.5M
Cap. Flow
+$2.6M
Cap. Flow %
1.4%
Top 10 Hldgs %
16.33%
Holding
136
New
11
Increased
60
Reduced
52
Closed
4

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$1.08M
2
BMY icon
Bristol-Myers Squibb
BMY
+$609K
3
MDLZ icon
Mondelez International
MDLZ
+$556K
4
SJM icon
J.M. Smucker
SJM
+$419K
5
UL icon
Unilever
UL
+$405K

Sector Composition

Rank Sector Weight
1 Technology 19.15%
2 Healthcare 17.44%
3 Industrials 14.91%
4 Consumer Discretionary 13.06%
5 Consumer Staples 12.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVS icon
51
CVS Health
CVS
$123B
$1.73M 0.93%
25,391
+731
+3% +$47.5K
CERN
52
DELISTED
Cerner Corp
CERN
$1.71M 0.92%
21,746
+275
+1% +$20.4K
DHI icon
53
D.R. Horton
DHI
$40.8B
$1.67M 0.9%
24,173
-855
-3% -$62.3K
LOW icon
54
Lowe's Companies
LOW
$122B
$1.66M 0.9%
10,370
-353
-3% -$57.3K
NVDA icon
55
NVIDIA
NVDA
$5.3T
$1.61M 0.87%
123,040
-14,320
-10% -$192K
SBUX icon
56
Starbucks
SBUX
$120B
$1.6M 0.86%
14,947
-20
-0.1% -$1.91K
AVY icon
57
Avery Dennison
AVY
$13.2B
$1.6M 0.86%
10,288
-195
-2% -$28.2K
KMB icon
58
Kimberly-Clark
KMB
$36.1B
$1.5M 0.81%
11,132
-274
-2% -$38.4K
BMY icon
59
Bristol-Myers Squibb
BMY
$131B
$1.47M 0.79%
23,614
+9,908
+72% +$609K
TXN icon
60
Texas Instruments
TXN
$254B
$1.47M 0.79%
8,927
+78
+0.9% +$12.1K
BKNG icon
61
Booking.com
BKNG
$156B
$1.46M 0.79%
16,350
+275
+2% +$21.2K
CLX icon
62
Clorox
CLX
$12.8B
$1.46M 0.78%
7,211
+755
+12% +$156K
NOC icon
63
Northrop Grumman
NOC
$80.7B
$1.42M 0.76%
4,657
+228
+5% +$69.8K
GPC icon
64
Genuine Parts
GPC
$18.3B
$1.42M 0.76%
14,108
+322
+2% +$31.5K
FDS icon
65
Factset
FDS
$9.77B
$1.4M 0.76%
4,219
+87
+2% +$28.8K
ROP icon
66
Roper Technologies
ROP
$39.3B
$1.39M 0.75%
3,234
+25
+0.8% +$10.3K
DOV icon
67
Dover
DOV
$28.4B
$1.37M 0.74%
10,858
AMD icon
68
Advanced Micro Devices
AMD
$799B
$1.32M 0.71%
14,394
-860
-6% -$74.2K
HD icon
69
Home Depot
HD
$349B
$1.32M 0.71%
4,959
+86
+2% +$23.6K
GOOG icon
70
Alphabet (Google) Class C
GOOG
$4.36T
$1.31M 0.71%
14,980
+20
+0.1% +$1.69K
FAST icon
71
Fastenal
FAST
$58.3B
$1.3M 0.7%
53,464
+160
+0.3% +$3.77K
INTC icon
72
Intel
INTC
$503B
$1.23M 0.66%
24,620
-987
-4% -$48.2K
SJM icon
73
J.M. Smucker
SJM
$12.7B
$1.18M 0.64%
10,231
+3,601
+54% +$419K
CHKP icon
74
Check Point Software Technologies
CHKP
$12.8B
$1.17M 0.63%
8,804
+210
+2% +$25.7K
ADI icon
75
Analog Devices
ADI
$184B
$1.16M 0.63%
7,852
-51
-0.6% -$6.76K

Similar funds

Eads & Heald Wealth Management's Q4 2020 Portfolio in Review

As of Q4 2020, Eads & Heald Wealth Management held 136 positions worth $186M, up 11% from $167M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Eads & Heald Wealth Management's Q4 2020 filing shows 11 new, 60 increased, 52 reduced and 4 closed positions. Its largest new stake was Salesforce: 4,449 shares worth $990K. The largest sale was Unilever NV New York Registry Shares, an estimated $370K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.

  • Eads & Heald Wealth Management's largest Q4 2020 buy was Salesforce: 4,449 shares worth $990K.
  • Eads & Heald Wealth Management added most to Bristol-Myers Squibb in Q4 2020, an estimated $609K increase.
  • Eads & Heald Wealth Management's biggest Q4 2020 reduction was Idexx Laboratories, cutting an estimated $269K.
  • Eads & Heald Wealth Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $370K.
  • Eads & Heald Wealth Management's ten largest holdings make up 16% of its $186M portfolio in Q4 2020.
  • Eads & Heald Wealth Management opened 11 new positions and closed 4 in Q4 2020.
  • Eads & Heald Wealth Management's portfolio value rose 11% quarter-over-quarter to $186M.

Based on Eads & Heald Wealth Management's 13F filing for Q4 2020, filed 2 Feb 2021.